Chemotherapy

Breaking barriers in breast cancer treatment: The shift towards personalised care

Dr Mark Verrill, Consultant Medical Oncologist at the Northern Centre for Cancer Care, discusses the importance of personalised breast cancer treatment.

Enhancing cancer care through genomic testing

Simon Holt, Honorary Professor at Swansea University, reflects on the key challenges within cancer care and the benefits of genomic testing in improving patient outcomes.

New study reveals chemical exposures linked to women’s Cancer risk

A recent study unveils alarming findings about women's cancer risk, indicating significant connections between the disease and exposure to certain endocrine-disrupting chemicals.

Cannabis for cancer: Improving sleep and pain tolerance

Could cannabis for cancer become a reality in patient wards? Researchers find the plant can improve sleep, pain, and brain clarity, easing 'chemo brain'.

Advancements in how we identify and treat hypoxic cancers

Cancers that are starved of oxygen, otherwise known as hypoxic cancers, are generally difficult to identify – but medical imaging has taken a new step with the MR-Linac scanner.

Why do some cancer patients not respond to immunotherapy?

Only half of patients with colorectal and endometrial cancer respond to immunotherapy, which is designed to recognise and attack cancer cells

Drone chemotherapy becomes an NHS net zero cancer strategy

NHS cancer patients will be the first to experience drone chemotherapy, which furthers the NHS net zero strategy, as it cuts down travel time and distance.

Drug for ovarian cancer shows 52% reduction in death

Scientists have began using trametinib – used to treat skin and lung cancers – for ovarian cancer, showing that it can significantly slow the progression of the cancer.

A look at brain tumour diagnosis & therapy

Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.

Honeybee venom found to kill agressive breast cancer cells

Researchers from the University of Western Australia have found that the venom of honeybees can destroy aggressive breast cancer cells in a lab setting.

Medicine authority can’t recommend CBD medicines to NHS

The National Institute for Health and Care Excellence (NICE) said they need more research into CBD medicines before the NHS can prescribe them in general.

Point-of-care devices technology for therapeutic drug monitoring in cancer treatment and beyond

Christian Siebel and Dott.ssa Bianca Posocco detail the work of DIACHEMO, a Euroepan project developing a platform technology for point-of-care devices for chemotherapeutics and other drugs.

New data reveals cancer diagnosis could affect treatment options

Data from Public Health England shows that cancer diagnosis could impact upon which kind of treatment a patient receives.

Chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML): Leukaemia patients watching and worrying

Bethany Torr, campaigns and advocacy officer at Leukaemia Care discusses the impact of chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML) on patients

Need for supportive care in oncology will increase during the next decade

The need for supportive care in oncology will increase as patients continue to live longer and cancer progresses to become more like a chronic...

Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid...

Acute myeloid leukaemia (AML)

Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government Acute myeloid leukaemia (AML) is a form...

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders